Medicare billing address
CMS Medicare provider billing file
200 Village DrGreensburg, PA 15601
CMS public data · NPI 1518498377
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Paul D Ehrlichman, DO
Specialty
Credential
DO
NPI
1518498377
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Paul D Ehrlichman, DO from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
200 Village DrCMS Doctors & Clinicians file
200 Village DrIn the 2024 CMS provider billing file, this NPI had 235 Medicare beneficiaries and 24,988 total services. The average beneficiary age was 74, and the average HCC risk score was 2.2.
Total Medicare allowed amount
$815,963.87
Total Medicare payment amount
$646,264.20
Medicare beneficiaries
235
Total services
24,988
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
40%
CMS beneficiary-panel share
Chronic kidney disease
36%
CMS beneficiary-panel share
Diabetes
34%
CMS beneficiary-panel share
Mood disorders
31%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, dexamethasone sodium phosphate, 1 mg | 306 | $0.12 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 163 | $143.55 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 137 | $105.24 |
| Administration of chemotherapy into vein, 1 hour or less | 71 | $116.63 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 67 | $26.11 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 63 | $15.67 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 59 | $7.61 |
| Injection of drug or substance under skin or into muscle | 46 | $13.40 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 46 | $123.75 |
| Injection of additional new drug or substance into vein | 31 | $14.13 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1518498377. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisone | Prednisone | 108 | 115.3 | $385.01 |
| 2 | Anastrozole | Anastrozole | 106 | 254.9 | $2,076.17 |
| 3 | Ondansetron Hcl | Ondansetron Hcl | 76 | 76 | $773.37 |
| 4 | Hydroxyurea | Hydroxyurea | 58 | 91.8 | $674.79 |
| 5 | Eliquis | Apixaban | 50 | 64 | $35,624.71 |
| 6 | Dexamethasone | Dexamethasone | 40 | 41 | $323.75 |
| 7 | Brukinsa | Zanubrutinib | 38 | 38 | $392,960.28 |
| 8 | Oxycodone Hcl | Oxycodone Hcl | 38 | 38 | $486.44 |
| 9 | Abiraterone Acetate | Abiraterone Acetate | 34 | 34 | $162,384.33 |
| 10 | Imbruvica | Ibrutinib | 32 | 32 | $468,219.80 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Philadelphia College Of Osteopathic Medicine
Graduation year
2017
Group/practice field
Hematology Oncology Association
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Medical Oncology.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.